If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPressure Tech Regulatory News (PRES)

  • There is currently no data for PRES

Exercise of Options

16 Feb 2017 12:42

RNS Number : 0960X
Pressure Technologies PLC
16 February 2017
 

16 February 2017

 

Pressure Technologies plc

("Pressure Technologies" or the "Company")

 

Exercise of Options

 

Pressure Technologies plc announces that it has issued and allotted 3,461 new ordinary shares of 5p each in the Company, following an exercise of options pursuant to the Company's SAYE scheme. The options were exercised at a price of 156 pence per share.

 

The new ordinary shares will rank pari passu with existing ordinary shares in the Company and application has been made for these new ordinary shares to be admitted to trading on AIM, which is expected to occur on or around 24 February 2017.

 

Total Voting Rights

 

In accordance with the Financial Conduct Authority's Disclosure and Transparency Rules, the total number of ordinary shares of 5 pence of Pressure Technologies in issue at the date of this notice is 14,482,670.

 

The above figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in Pressure Technologies, under the Disclosure and Transparency Rules.

For further information, please contact:

 

Pressure Technologies plc

Keeley Clarke, Investor Relations

 

Tel: 0114 257 3622

www.pressuretechnologies.com

Cantor Fitzgerald Europe

(Nominated Adviser and Broker)

Tel: 020 7894 7000

Philip Davies / Will Goode

 

COMPANY DESCRIPTION

 

Company description - www.pressuretechnologies.com

 

With its head office in Sheffield, Pressure Technologies was founded on its leading market position as a designer and manufacturer of high-pressure systems serving the global energy, defence and industrial gases markets. Today it continues to serve those markets from a broader engineering base with specialist precision engineering businesses and has a worldwide presence in Alternative Energy as a global leader in biogas upgrading. On this foundation, the company is building a highly profitable group of companies through a combination of organic initiatives and acquisitions.

 

Pressure Technologies has four divisions, Precision Machined Components, Engineered Products, Cylinders and Alternative Energy, serving four markets: oil and gas, defence, industrial gases and alternative energy.

 

Precision Machined Components

· Al-Met, Mid Glamorgan, acquired in 2010 www.almet.co.uk

· Roota Engineering, Rotherham, acquired in March 2014 www.roota.co.uk

· Quadscot, Glasgow, acquired in October 2014 www.quadscot.co.uk

· Martract Limited, Barton-on-Humber, acquired in December 2016 www.martract.co.uk

 

Engineered Products

· Hydratron, Manchester, acquired in 2010 www.hydratron.com

 

Cylinders

· Chesterfield Special Cylinders, Sheffield, IPO cornerstone in 2007 www.chesterfieldcylinders.com

· Kelley GTM Manufacturing, Amarillo, USA - 40% stake acquired by the Group in December 2013 www.kelleygtm.com

 

Alternative Energy

· Greenlane Biogas, Sheffield, UK; Vancouver, Canada and; Auckland, New Zealand acquired in October 2014 www.greenlanebiogas.com

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IOEEAAAKFLFXEFF
Date   Source Headline
9th Feb 202111:00 amRNSPrice Monitoring Extension
9th Feb 20219:06 amRNSSecond Price Monitoring Extn
9th Feb 20219:00 amRNSPrice Monitoring Extension
9th Feb 20217:00 amRNSContract Win for Hydrogen Refuelling Stations
14th Jan 20217:00 amRNSPressure Technologies plc 2020 Preliminary Results
29th Dec 202011:06 amRNSSecond Price Monitoring Extn
29th Dec 202011:01 amRNSPrice Monitoring Extension
22nd Dec 20206:24 pmRNSHolding(s) in Company
21st Dec 20205:37 pmRNSHolding(s) in Company
21st Dec 20203:49 pmRNSHolding(s) in Company
21st Dec 20203:40 pmRNSHolding(s) in Company
17th Dec 20204:41 pmRNSHolding(s) in Company
17th Dec 202012:37 pmRNSResult of General Meeting
11th Dec 20204:40 pmRNSSecond Price Monitoring Extn
11th Dec 20204:35 pmRNSPrice Monitoring Extension
11th Dec 20202:06 pmRNSSecond Price Monitoring Extn
11th Dec 20202:00 pmRNSPrice Monitoring Extension
10th Dec 20204:42 pmRNSHolding(s) in Company
9th Dec 202011:21 amRNSHolding(s) in Company
7th Dec 20204:43 pmRNSHolding(s) in Company
7th Dec 20203:49 pmRNSHolding(s) in Company
4th Dec 20202:36 pmRNSHolding(s) in Company
3rd Dec 202010:55 amRNSHolding(s) in Company
1st Dec 20207:00 amRNSResult of Placing and PrimaryBid Offer
30th Nov 20204:36 pmRNSPrimaryBid Offer
30th Nov 20204:35 pmRNSProposed Placing and PrimaryBid Offer
3rd Nov 20207:00 amRNSFull Year Trading Update
21st Oct 20207:00 amRNSBoard Changes
30th Sep 20207:00 amRNSMajor Contracts and Trading Update
20th Aug 20207:00 amRNSBoard Changes
24th Jul 20204:26 pmRNSGrant of Share Options
3rd Jul 20207:35 amRNSDisposal of equity holding in Greenlane Renewables
23rd Jun 20207:01 amRNS2020 Interim Results
23rd Jun 20207:00 amRNSBoard changes
16th Apr 20202:08 pmRNSDirector Shareholding
14th Apr 20201:09 pmRNSDirector Shareholding
9th Apr 20207:00 amRNSUPDATE ON TRADING AND COVID-19 IMPACT
17th Mar 20207:00 amRNSDirector Shareholding
13th Mar 20207:00 amRNSDirector Shareholding
5th Mar 20207:00 amRNSResult of AGM
28th Feb 20203:00 pmRNSDirector Shareholding
25th Feb 202011:15 amRNSFurther re: Proposed Offering by Greenlane
19th Feb 20207:00 amRNSDirector Shareholding
12th Feb 20207:00 amRNSFurther re: Proposed Offering by Greenlane
11th Feb 20204:40 pmRNSDirector Shareholding
11th Feb 20207:00 amRNSProposed offering by Greenlane Renewables Inc.
10th Feb 202011:19 amRNSPurchase of shares by a Director
30th Jan 20207:00 amRNSPublication of Annual Report and Notice of AGM
28th Jan 20207:00 amRNSBoard Change
23rd Jan 20207:00 amRNSBoard Changes

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.